U.S. flag

An official website of the United States government

Format
Items per page
Sort by

Send to:

Choose Destination

Links from GEO DataSets

Items: 12

1.

Development of a glycan microarray based method for ABO blood typing

(Submitter supplied) Purpose: This study uses a high-throughput glycan microarray to develop a novel method to assign ABO blood type. The method will then be applied to samples from patients treated with PROSTVAC to determine if blood type correlates with survival Results: Many blood group A and B antigens correlate with blood type. Blood typing is best achieved using a combination of 10 signals Conclusion: ABO blood type can be determined with greater than 97% accuracy using only 4 microliters of serum.
Organism:
Quercus alba; Gossypium hirsutum; Pandalus borealis; Oncorhynchus nerka; Homo sapiens; Gallus gallus; Ovis aries; Ceratonia siliqua; Megathura crenulata; Frangula alnus; Rhodotorula; Mus musculus; Bothrops moojeni; Senegalia senegal; Pachymenia carnosa; Dermestes lardarius; Trypanosoma cruzi; Bos taurus
Type:
Other
Platform:
GPL20116
220 Samples
Download data: TXT
Series
Accession:
GSE68403
ID:
200068403

PubMed Full text in PMC Similar studies

2.

A Simple, Inexpensive Strategy for Predicting Potential Beneficial Clinical Responses on Prostate Cancer Vaccine Therapy

(Submitter supplied) This SuperSeries is composed of the SubSeries listed below.
Organism:
Quercus alba; Megathura crenulata; Pandalus borealis; Oncorhynchus nerka; Ovis aries; Ceratonia siliqua; Frangula alnus; Senegalia senegal; Dermestes lardarius; Trypanosoma cruzi; Gallus gallus; Bothrops moojeni; Pachymenia carnosa; Gossypium hirsutum; Rhodotorula; Homo sapiens; Bos taurus; Mus musculus
Type:
Other
Platforms:
GPL20117 GPL20116
331 Samples
Download data
Series
Accession:
GSE68405
ID:
200068405

PubMed Full text in PMC Similar studies

3.

Determination of ABO blood type for prostate cancer patients

(Submitter supplied) Purpose: This study uses a high-throughput glycan microarray to assign ABO blood type to patients from a clinical trial on PROSTVAC. The goal is to determine if blood type correlates with survival for patients treated with PROSTVAC Results: Blood types were assigned and type B and O patients were found to have longer survival than type A and AB patients Conclusion: Blood type may serve as a convenient method to identify patients likely to respond favorably to PROSTVAC therapy
Organism:
Gallus gallus; Frangula alnus; Homo sapiens
Type:
Other
Platform:
GPL20117
111 Samples
Download data: TXT
Series
Accession:
GSE68404
ID:
200068404

PubMed Full text in PMC Similar studies

4.

Baseline serum anti-glycan antibodies of 113 subjects in a clinical trial of PROSTVAC-VF, a therapeutic cancer vaccine

(Submitter supplied) This SuperSeries is composed of the SubSeries listed below.
Organism:
Quercus alba; Pandalus borealis; Bothrops moojeni; Senegalia senegal; Dermestes lardarius; Gossypium hirsutum; Rhodotorula; Homo sapiens; Bos taurus; Mus musculus; Medicago sativa; Gallus gallus; Pachymenia carnosa; Ovis aries; Megathura crenulata; Frangula alnus
Type:
Protein profiling by protein array
Platforms:
GPL16242 GPL16262
564 Samples
Download data: TXT
Series
Accession:
GSE42184
ID:
200042184

PubMed Full text in PMC Similar studies Analyze with GEO2R

5.

Baseline serum anti-glycan antibodies of 113 subjects in a clinical trial of PROSTVAC-VF, a therapeutic cancer vaccine [Validation Total Ig 1:200]

(Submitter supplied) Purpose: There is evidence that therapeutic cancer vaccines can lengthen survival for some cancer patients, but responses vary widely from one person to another. Methods to predict clinical outcomes will advance the field and provide new insights into critical determinants of in vivo efficacy. This study uses a high-throughput glycan microarray to assess correlations between a subject's overall survival after receiving PROSTVAC-VF and his baseline serum anti-glycan antibody levels. more...
Organism:
Medicago sativa; Gallus gallus; Megathura crenulata; Quercus alba; Bothrops moojeni; Pachymenia carnosa; Gossypium hirsutum; Pandalus borealis; Homo sapiens; Rhodotorula; Bos taurus; Ovis aries; Mus musculus; Frangula alnus; Senegalia senegal; Dermestes lardarius
Type:
Protein profiling by protein array
Platform:
GPL16242
113 Samples
Download data
Series
Accession:
GSE42179
ID:
200042179

PubMed Full text in PMC Similar studies Analyze with GEO2R

6.

Baseline serum anti-glycan antibodies of 113 subjects in a clinical trial of PROSTVAC-VF, a therapeutic cancer vaccine [Validation Total Ig 1:50]

(Submitter supplied) Purpose: There is evidence that therapeutic cancer vaccines can lengthen survival for some cancer patients, but responses vary widely from one person to another. Methods to predict clinical outcomes will advance the field and provide new insights into critical determinants of in vivo efficacy. This study uses a high-throughput glycan microarray to assess correlations between a subject's overall survival after receiving PROSTVAC-VF and his baseline serum anti-glycan antibody levels. more...
Organism:
Gossypium hirsutum; Rhodotorula; Homo sapiens; Bos taurus; Mus musculus; Quercus alba; Pandalus borealis; Bothrops moojeni; Senegalia senegal; Pachymenia carnosa; Dermestes lardarius; Ovis aries; Megathura crenulata; Frangula alnus; Medicago sativa; Gallus gallus
Type:
Protein profiling by protein array
Platform:
GPL16242
113 Samples
Download data
Series
Accession:
GSE42176
ID:
200042176

PubMed Full text in PMC Similar studies Analyze with GEO2R

7.

Baseline serum anti-glycan antibodies of 113 subjects in a clinical trial of PROSTVAC-VF, a therapeutic cancer vaccine [Validation IgM 1:50]

(Submitter supplied) Purpose: There is evidence that therapeutic cancer vaccines can lengthen survival for some cancer patients, but responses vary widely from one person to another. Methods to predict clinical outcomes will advance the field and provide new insights into critical determinants of in vivo efficacy. This study uses a high-throughput glycan microarray to assess correlations between a subject's overall survival after receiving PROSTVAC-VF and his baseline serum anti-glycan antibody levels. more...
Organism:
Gossypium hirsutum; Rhodotorula; Homo sapiens; Bos taurus; Mus musculus; Pandalus borealis; Ovis aries; Frangula alnus; Senegalia senegal; Dermestes lardarius; Medicago sativa; Gallus gallus; Bothrops moojeni; Pachymenia carnosa; Quercus alba; Megathura crenulata
Type:
Protein profiling by protein array
Platform:
GPL16242
113 Samples
Download data
Series
Accession:
GSE42175
ID:
200042175

PubMed Full text in PMC Similar studies Analyze with GEO2R

8.

Baseline serum anti-glycan antibodies of 113 subjects in a clinical trial of PROSTVAC-VF, a therapeutic cancer vaccine [Validation IgG 1:50]

(Submitter supplied) Purpose: There is evidence that therapeutic cancer vaccines can lengthen survival for some cancer patients, but responses vary widely from one person to another. Methods to predict clinical outcomes will advance the field and provide new insights into critical determinants of in vivo efficacy. This study uses a high-throughput glycan microarray to assess correlations between a subject's overall survival after receiving PROSTVAC-VF and his baseline serum anti-glycan antibody levels. more...
Organism:
Medicago sativa; Gallus gallus; Ovis aries; Megathura crenulata; Frangula alnus; Bothrops moojeni; Pachymenia carnosa; Quercus alba; Gossypium hirsutum; Pandalus borealis; Homo sapiens; Rhodotorula; Bos taurus; Mus musculus; Senegalia senegal; Dermestes lardarius
Type:
Protein profiling by protein array
Platform:
GPL16242
113 Samples
Download data
Series
Accession:
GSE42163
ID:
200042163

PubMed Full text in PMC Similar studies Analyze with GEO2R

9.

Baseline serum anti-glycan antibodies of 28 subjects in a clinical trial of PROSTVAC-VF, a therapeutic cancer vaccine [Training Total Ig 1:200]

(Submitter supplied) Purpose: There is evidence that therapeutic cancer vaccines can lengthen survival for some cancer patients, but responses vary widely from one person to another. Methods to predict clinical outcomes will advance the field and provide new insights into critical determinants of in vivo efficacy. This study uses a high-throughput glycan microarray to assess correlations between a subject's overall survival after receiving PROSTVAC-VF and his baseline serum anti-glycan antibody levels. more...
Organism:
Pandalus borealis; Frangula alnus; Senegalia senegal; Dermestes lardarius; Gossypium hirsutum; Rhodotorula; Homo sapiens; Bos taurus; Mus musculus; Gallus gallus; Bothrops moojeni; Pachymenia carnosa; Quercus alba; Ovis aries; Megathura crenulata
Type:
Protein profiling by protein array
Platform:
GPL16262
28 Samples
Download data
Series
Accession:
GSE42150
ID:
200042150

PubMed Full text in PMC Similar studies Analyze with GEO2R

10.

Baseline serum anti-glycan antibodies of 28 subjects in a clinical trial of PROSTVAC-VF, a therapeutic cancer vaccine [Training Total Ig 1:50]

(Submitter supplied) Purpose: There is evidence that therapeutic cancer vaccines can lengthen survival for some cancer patients, but responses vary widely from one person to another. Methods to predict clinical outcomes will advance the field and provide new insights into critical determinants of in vivo efficacy. This study uses a high-throughput glycan microarray to assess correlations between a subject's overall survival after receiving PROSTVAC-VF and his baseline serum anti-glycan antibody levels. more...
Organism:
Gallus gallus; Mus musculus; Megathura crenulata; Quercus alba; Bothrops moojeni; Pachymenia carnosa; Gossypium hirsutum; Pandalus borealis; Homo sapiens; Rhodotorula; Bos taurus; Ovis aries; Frangula alnus; Senegalia senegal; Dermestes lardarius
Type:
Protein profiling by protein array
Platform:
GPL16262
28 Samples
Download data
Series
Accession:
GSE42145
ID:
200042145

PubMed Full text in PMC Similar studies Analyze with GEO2R

11.

Baseline serum anti-glycan antibodies of 28 subjects in a clinical trial of PROSTVAC-VF, a therapeutic cancer vaccine [Training IgM 1:50]

(Submitter supplied) Purpose: There is evidence that therapeutic cancer vaccines can lengthen survival for some cancer patients, but responses vary widely from one person to another. Methods to predict clinical outcomes will advance the field and provide new insights into critical determinants of in vivo efficacy. This study uses a high-throughput glycan microarray to assess correlations between a subject's overall survival after receiving PROSTVAC-VF and his baseline serum anti-glycan antibody levels. more...
Organism:
Quercus alba; Bothrops moojeni; Pachymenia carnosa; Medicago sativa; Gallus gallus; Megathura crenulata; Gossypium hirsutum; Pandalus borealis; Homo sapiens; Rhodotorula; Bos taurus; Ovis aries; Mus musculus; Frangula alnus; Senegalia senegal; Dermestes lardarius
Type:
Protein profiling by protein array
Platform:
GPL16242
28 Samples
Download data
Series
Accession:
GSE42020
ID:
200042020

PubMed Full text in PMC Similar studies Analyze with GEO2R

12.

Baseline serum anti-glycan antibodies of 28 subjects in a clinical trial of PROSTVAC-VF, a therapeutic cancer vaccine [Training IgG 1:50]

(Submitter supplied) Purpose: There is evidence that therapeutic cancer vaccines can lengthen survival for some cancer patients, but responses vary widely from one person to another. Methods to predict clinical outcomes will advance the field and provide new insights into critical determinants of in vivo efficacy. This study uses a high-throughput glycan microarray to assess correlations between a subject's overall survival after receiving PROSTVAC-VF and his baseline serum anti-glycan antibody levels. more...
Organism:
Quercus alba; Bothrops moojeni; Pachymenia carnosa; Gossypium hirsutum; Rhodotorula; Gallus gallus; Mus musculus; Megathura crenulata; Bos taurus; Ovis aries; Frangula alnus; Senegalia senegal; Dermestes lardarius; Medicago sativa; Pandalus borealis; Homo sapiens
Type:
Protein profiling by protein array
Platform:
GPL16242
28 Samples
Download data
Series
Accession:
GSE42019
ID:
200042019

PubMed Full text in PMC Similar studies Analyze with GEO2R

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Filters: Manage Filters

db=gds|term=|query=31|qty=20|blobid=MCID_671fc200e158b40557cadec6|ismultiple=true|min_list=5|max_list=20|def_tree=20|def_list=|def_view=|url=/Taxonomy/backend/subset.cgi?|trace_url=/stat?
   Taxonomic Groups  [List]
Tree placeholder
    Top Organisms  [Tree]

Find related data

Important Links

Recent activity

Clear Turn Off Turn On

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...
You are here: NCBI > Genes & Expression > Gene Expression Omnibus (GEO) Datasets
Support Center